304 related articles for article (PubMed ID: 33725867)
1. NK cells adjuvant therapy shows survival benefits in a gastric mixed signet ring cell carcinoma patient: A case report.
Jin YY; Yang WZ; Sun ZY; Wang ZB; Chen J; Wu CT; Yang ZY
Medicine (Baltimore); 2021 Mar; 100(10):e24979. PubMed ID: 33725867
[TBL] [Abstract][Full Text] [Related]
2. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Prognostic Analysis of Patients With Signet Ring Cell Gastric Carcinoma.
Yu JM; Zhan ZW; Zhen JX; Wang XJ; Chen Y; Lin J; Chen L; Chen LZ; Huang YF; Guo ZQ
Technol Cancer Res Treat; 2020; 19():1533033820983812. PubMed ID: 33371800
[TBL] [Abstract][Full Text] [Related]
4. [Gastric signet ring cell adenocarcinoma: A distinct entity].
Tabouret T; Dhooge M; Rouquette A; Brezault C; Beuvon F; Chaussade S; Coriat R
Presse Med; 2014 Apr; 43(4 Pt 1):353-7. PubMed ID: 24440764
[TBL] [Abstract][Full Text] [Related]
5. Differences in clinicopathological characteristics and computed tomography findings between signet ring cell carcinoma and nonsignet ring cell carcinoma in early and advanced gastric cancer.
Chen J; Cai R; Ren G; Zhao J; Li H; Guo C; He W; Wu X; Zhang W
Cancer Med; 2018 Apr; 7(4):1160-1169. PubMed ID: 29533002
[TBL] [Abstract][Full Text] [Related]
6. CRS + HIPEC combined with IP + IV chemotherapy for gastric signet-ring cell carcinoma: Case report of long-term survival.
Yan GJ; Ji ZH; Liu G; Li Y
Medicine (Baltimore); 2020 Oct; 99(41):e22647. PubMed ID: 33031325
[TBL] [Abstract][Full Text] [Related]
7. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
[TBL] [Abstract][Full Text] [Related]
8. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
9. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
10. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
11. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
12. Is signet-ring cell carcinoma a specific entity among gastric cancers?
Voron T; Messager M; Duhamel A; Lefevre J; Mabrut JY; Goere D; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C; Paye F
Gastric Cancer; 2016 Oct; 19(4):1027-1040. PubMed ID: 26606931
[TBL] [Abstract][Full Text] [Related]
13. [Data review and analysis of 22 cases of gastric cancer associated with pregnancy].
Jiang ZC; Chi Y
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):631-635. PubMed ID: 30139036
[No Abstract] [Full Text] [Related]
14. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
15. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the research of gastric signet ring cell carcinoma].
Xu Z; Jin Y; Fang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1196-1200. PubMed ID: 30370520
[TBL] [Abstract][Full Text] [Related]
19. Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis.
Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
J Surg Oncol; 2016 Oct; 114(5):607-612. PubMed ID: 27562147
[TBL] [Abstract][Full Text] [Related]
20. Surgical Resection First for Localized Gastric Adenocarcinoma: Are There Adjuvant Options?
Elimova E; Ajani JA
J Clin Oncol; 2015 Oct; 33(28):3085-91. PubMed ID: 26324361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
